17th Annual Advances in Autism Conference
Icahn School of Medicine at Mount Sinai, Seaver Autism Center for Research and Treatment presents the seventeenth Advances in Autism Conference. There are ten National Institutes of Health Autism Centers of Excellence in the United States. At the 17th Annual Advances in Autism Conference, representatives of three of these Centers, including two from the Seaver Autism Center, will present updates on the ongoing research.
Icahn School of Medicine at Mount Sinai Seaver Autism Center for Research and Treatment PRESENTS THE SEVENTEENTH Advances in Autism Conference Sunday October 6, 2013 STERN AUDITORIUM ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NEW YORK, NY COURSE DIRECTOR JOSEPH D. BUXBAUM, PHD SPECIAL GUEST SPEAKER: LINMARIE SIKICH, MD Associate Professor and Director of the Adolescent and School-age Psychiatric Intervention Research Program (ASPIRE) University of North Carolina at Chapel Hill School of Medicine DISTINGUISHED SCIENTIFIC SPEAKERS: Joseph D. Buxbaum, PhD Abraham (Avi) Reichenberg, PhD Ting Wang, PhD There are ten National Institutes of Health Autism Centers of Excellence in the United States. At the 17th Annual Advances in Autism Conference, representatives of three of these Centers, including two from the Seaver Autism Center, will present updates on the ongoing research. SCHEDULE FOR SUNDAY, OCTOBER 6th, 2013 8:30 AM Registration 9:00 Opening Remarks Joseph D. Buxbaum John D. Cohen Melanie Goldberg 9:45 Novel Therapeutic Approaches in Autism Spectrum Disorders Joseph D. Buxbaum 10:30 Coffee Break 10:45 My Brother, My Friend Jamie Rosenblum 11:00 Brain and Behavioral Effects of Social Skills Treatment in ASD A. Ting Wang 11:45 Environmental Factors and Autism Risk Avi Reichenberg 12:30PM Lunch 1:30 Afternoon Introductions Hirschell Levine Lee Rambeau 2:00 Keynote Presentation: Studying Oxytocin in Autism Spectrum Disorders: Great Promise or Great Hype? Linmarie Sikich 3:00-4:30 Workshops (A, B, C) WORKSHOP A Psychosocial Interventions in Autism Spectrum Disorders: From Research to the Community Michelle Gorenstein-Holtzman Danielle Halpern A. Ting Wang WORKSHOP B Current Trends in the Pharmacological Treatment of Autism: A Panel of Experts Alexander Kolevzon David Grodberg Charles Cartwright Peter Della Bella WORKSHOP C Transitioning Across the Spectrum: A Focus on Education, Residential Opportunities, and Day Programming Samantha Feinman Harry Nussbaum Jennifer Shaoul Tom Ott Register Online at www.seaverconference2013.eventbrite.com ADVANCES IN AUTISM CONFERENCE October 6, 2013 CONFERENCE SPEAKERS Joseph Buxbaum, PhD Michelle Gorenstein-Holtzman, PsyD Harry Nussbaum G. Harold and Leila Y. Mathers Professor Departments of Psychiatry, Genetics and Genomic Sciences, and Neuroscience Director, Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai Assistant Professor Director of Community Outreach Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai David Grodberg, MD Charles Cartwright, MD Director YAI Autism Center YAI Network Assistant Professor Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai John D. Cohen, LLB Doctor of Humane Letters (Honorary, Yeshiva University) Trustee, Beatrice and Samuel A. Seaver Foundation Retired Partner, Chair of Real Estate Department, Tenzer, Greenblatt, Fallon & Kaplan Danielle Halpern, PsyD Assistant Clinical Professor Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai Medical Director YAI/Premier HealthCare Samantha J. Feinman, MSEd, TSHH Program Director New Frontiers in Learning Melanie Goldberg, LMSW Planning Associate, Caring Commission UJA-Federation of New York Tom Ott, LCSW Intake Coordinator, YAI Residential Supports Therapist, YAI Center for Specialty Therapy Lee Rambeau, MPA Senior Vice President Community and Employment Supports F•E•G•S Health and Human Services System Jamie Rosenblum Sibling of Adult with Autism Jennifer Shaoul, MPA Alex Kolevzon, MD Peter Della Bella, MD Associate Vice President F•E•G•S Health and Human Services System Clinical Director Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai Hirschell Levine, JD, CPA, LLB, LLM (Taxation) Doctor of Humane Letters (Honorary, Yeshiva University) Trustee, Beatrice and Samuel A. Seaver Foundation Retired Managing Partner, Eisner & Lubin Consultant Trusts & Estates, Withum Smith & Brown Senior Coordinator, YAI LINK YAI/NIPD Linmarie Sikich, MD Associate Professor Director of the ASPIRE Program University of North Carolina at Chapel Hill A. Ting Wang, PhD Assistant Professor Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai CONFERENCE SUPPORTERS WE WOULD LIKE TO ACKNOWLEDGE THE GENEROUS SUPPORT OF: Deanna & Hirschell Levine Helen L. Kimmel Revocable Trust Ann & John Cohen William D. & Deborah Miller Zabel The Beatrice & Samuel A. Seaver Foundation Kathryn E. Spence Family Foundation Thomas and Jeanne Elmezzi Private Foundation Estate of Ann Schlaifer Betty & John Levin Denise and Andrew Saul Foundation DISTINGUISHED SCIENTIFIC SPEAKERS Joseph Buxbaum Joseph D. Buxbaum, PhD is the G. Harold and Leila Y. Mathers Professor of Psychiatry, Neuroscience, and Genetic and Genomic Sciences, the Head of The Laboratory of Molecular Neuropsychiatry, and the Vice Chair for Research in the Department of Psychiatry at Mount Sinai. Dr. Buxbaum is the Director of the Seaver Autism Center, and his research focuses on using techniques of molecular genetics and neurobiology to identify, and ultimately characterize, genes that contribute to autism susceptibility. His laboratory has identified common and rare genetic variants that underlie autism spectrum disorders and has developed model systems in which novel therapeutics can be tested. In addition, Dr. Buxbaum has taken a lead in several international consortia, most recently the Autism Sequencing Consortium aimed at sequencing 20,000 exomes, dedicated to advancing research in autism spectrum disorders. Dr. Buxbaum is the author of more than 200 publications, and he is co-editor-in-chief of the journal Molecular Autism (www.molecularautism.com). A. Ting Wang A. Ting Wang, PhD, is an Assistant Professor in the departments of Psychiatry and Neuroscience at Mount Sinai. She graduated from Amherst College and received a doctoral degree in Developmental Psychology from UCLA, studying with Dr. Marian Sigman and training in functional neuroimaging with Dr. Mirella Dapretto. She then completed a postdoctoral fellowship at the Seaver Autism Center before joining the faculty. Dr. Wangâ€™s research interest is in understanding the neural architecture supporting social communication skills and how these networks are impaired in autism. Her work integrates neuroimaging with various treatment approaches, both psychosocial and pharmacological, to identify neural predictors and correlates of response to treatment, and, more broadly, to examine the plasticity of the neural systems associated with core symptom domains. Dr. Wang is the recipient of dissertation and Young Investigator awards from the International Society for Autism Research, as well as grant awards from the NIMH, Autism Speaks, and NARSAD. Avi Reichenberg Dr. Reichenberg is a neuropsychologist and epidemiologist. His research focuses on understanding how environmental and genetic factors contribute to the etiology of developmental disorders, particularly autism and schizophrenia. He is a Professor of Psychiatry and Preventive Medicine at Icahn School of Medicine at Mount Sinai, and a Fellow of the Seaver Autism Center Research and Treatment. He is the director of the NIH funded Autism Center of Excellence Network studying multigenerational familial and environmental risk factors for autism. Keynote Speaker Linmarie Sikich Dr. Linmarie Sikich is a child and adolescent psychiatrist at the University of North Carolina at Chapel Hill. Prior to completing her residency she completed a masterâ€™s degree and postdoctoral fellowship focused on rodent cortical development. She initiated the TEACCH Medical Consultation Clinic, whose goal is to facilitate the integration of biomedical, behavioral and educational treatments for individuals with autism spectrum disorders (ASD), and directs the Adolescent and School-aged Psychiatric Intervention and REsearch (ASPIRE) program, which focuses on the development and evaluation of treatments for youth with psychiatric and developmental problems. She has participated in several psychopharmacologic clinical trials for individuals with ASD funded by foundations, the federal government and individual pharmaceutical companies. She is currently the lead PI of an ACE Network focusing on the study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B). She has previously participated in NIH, Cure Autism Now and Autism Speaks conferences examining appropriate outcome measures for autism intervention trials and emerging intervention strategies for ASD and Fragile X Syndrome. She has served as a reviewer of research proposals to the MIND Institute, Thrasher Institute, Autism Speaks, and was the chair of the National Institute of Mental Health Interventions for Children (ITVC) Study Section from 2010 - 2013. She is a member of the Autism Speaks Autism Treatment Network research advisory board and the Data and Safety Monitoring Board for the National Institute of Child Health and Human Development rare diseases network. STATEMENT OF NEED With the increasing rate of autism diagnoses and a rapidly aging young adult population with autism, there is a need to increase the sophistication of the diagnosis, assessment, and treatment of autism and autism spectrum disorders and share this information with psychiatrists, neurologists, other health care professionals, and consumers/family members. This is the main purpose of the Advances in Autism Conference. The goal of the Conference is a general update and enhancement of knowledge related to the accurate recognition, diagnosis, and treatment of autism spectrum disorders. With this knowledge, physicians, health care professionals, and teachers can better serve people with autism and provide optimal services to their patients with autism spectrum disorders. For families who attend, this conference will inform them of the current trends in diagnosis, research, and treatment and provide information on options/resources they might otherwise not have had access to. Our conference is an annual one-day event held at Icahn School of Medicine at Mount Sinai. It includes a series of lectures and workshops given by accomplished professionals in the field of autism. The purpose of the conference is to advance knowledge of the practicing psychiatrist, neurologist, psychologist, geneticist, other health care professional, educator, family member and social worker as to the accurate recognition, diagnosis, and treatment of autism spectrum disorders. PROGRAM OBJECTIVES At the conclusion of this activity, participants will be able to: ■ Assess the current psychological, neurological, functional imaging, and neurotransmitter model systems of autism. ■ Learn about advances in understanding the causes of autism and how this may lead to improved treatments. ■ Evaluate current pharmacological, behavioral, educational, and group treatments of autism. ■ Integrate the current diagnostic measures and treatment options for autism spectrum disorders into private practice. Target Audience This activity is designed for psychiatrists, neurologists, psychologists, pediatricians, geneticists, other health care professionals, educators, family members, and social workers. Verification of attendance will be provided to participants upon request. FACULTY DISCLOSURE & SPECIAL NEEDS Faculty Disclosure It is the policy of Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all educational activities. All faculty participating in the planning or implementation of an activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials. Special Needs Icahn School of Medicine at Mount Sinai is in full compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special accommodations, please contact Jessica Brownfeld at 212-241-0349. REGISTRATION FEES AND MEETING INFORMATION Registration Information FEE Practicing Physicians, Health Care Professionals, & Educators $175 Mount Sinai & Affiliated Faculty $125 Fellows*, Residents*, Family Members, & Students $85 * Letter required from Program Director A limited number of scholarships to attend the conference are available. Please note that no refunds will be issued after September 20, 2013. Meeting Location Icahn School of Medicine at Mount Sinai Annenberg Building, Stern Auditorium 1468 Madison Avenue (@100th Street) New York, NY 10029 Directions http://www.icahn.mssm.edu/about-us/visiting-us Parking Parking is available on East 99th Street (between Madison & Park Avenues). Information For conference and registration information, please e-mail email@example.com or call (212) 241-0349. REGISTRATION Advances in Autism Conference Sunday, October 6, 2013 THREE WAYS TO REGISTER LAST NAME, FIRST NAME Fax completed registration to 212-828-4221 Online at www.seaverconference2013.eventbrite.com Mail this form with your check to: CREDENTIALS (MD, PHD, RN, ETC.) Seaver Autism Center Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place, Box 1230 New York, NY 10029 Attn: Jessica Brownfeld ADDRESS CITY, STATE, ZIP Enclosed is my check for $ The Seaver Autism Center TELEPHONE payable to Please note that registration will not be processed unless accompanied by payment. E-MAIL Bill my credit card $ SPECIALTY ■ Visa ■ Mastercard ■ American Express INSTITUTION/AFFILIATION CARD #: REGISTRATION INFORMATION FEE EXP DATE ■ Practicing Physicians, Health Care Professionals, & Educators $175 ■ Mount Sinai & Affiliated Faculty $125 ■ Fellows*, Residents*, Family Members, & Students $85 CARD HOLDER NAME (please print) SIGNATURE * Letter required from Program Director A limited number of scholarships to attend the conference are available. WORKSHOP SESSIONS Please select the desired workshop you wish to attend. Afternoon Workshops 3:00PM – 4:30PM ■ WORKSHOP A Psychosocial Interventions in Autism Spectrum Disorders: From Research to the Community CANCELLATION POLICY For conference and registration information, please e-mail firstname.lastname@example.org or call (212) 241-0349. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SEAVER AUTISM CENTER FOR RESEARCH AND TREATMENT ■ WORKSHOP B Current Trends in the Pharmacological Treatment of Autism: A Panel of Experts ■ WORKSHOP C Transitioning Across the Spectrum: A Focus on Education, Residential Opportunities, and Day Programming Please indicate special dietary needs: ■ Kosher ■ Vegetarian Visit our website at www.seaverautismcenter.org